Skip to main content
Equibles

MORGAN STANLEY

Position in AURA — Aura Biosciences, Inc.

CIK 895421 NEW YORK, NY
Back to AURA Full portfolio

Position in AURA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,240,311
-$258,521 QoQ
Shares Held
174,692
-22.0% QoQ
Ownership
0.168%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 146 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 94% Shared 0% None 6%

Common Shares in AURA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. AURA ranks #243 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in AURA

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,240,311 174,692
2026-03-31 $1,498,832 224,041
2025-12-31 $1,190,316 218,407
2025-09-30 $1,103,158 178,505
2025-06-30 $940,800 150,288
2025-03-31 $582,757 99,447
2024-12-31 $1,340,096 163,029
2024-09-30 $1,639,384 183,994
2024-06-30 $626,266 82,840
2024-03-31 $681,816 86,856
2023-12-31 $733,313 82,767
2023-09-30 $189,122 21,084
2023-06-30 $996,211 80,665
2023-03-31 $673,660 72,593
2022-12-31 $678,330 64,603
2022-09-30 $999,352 55,152
2022-06-30 $772,816 54,539
2022-03-31 $24,398 1,109
2021-12-31 $9,066 534